TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Novimedica AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
193
|
190
|
135 |
Financial expenses |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
130
|
114
|
46 |
EBITDA |
127
|
114
|
46 |
Total assets |
164
|
141
|
120 |
Current assets |
163
|
140
|
119 |
Current liabilities |
43
|
33
|
25 |
Equity capital |
119
|
106
|
93 |
- share capital |
9
![]() |
9
|
10 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
72.6%
|
75.2%
|
77.5% |
Turnover per employee |
193
|
190
|
135 |
Profit as a percentage of turnover |
67.4%
|
60.0%
|
34.1% |
Return on assets (ROA) |
79.3%
|
80.9%
|
38.3% |
Current ratio |
379.1%
|
424.2%
|
476.0% |
Return on equity (ROE) |
109.2%
|
107.5%
|
49.5% |
Change turnover |
2
|
66
|
-49 |
Change turnover % |
1%
|
53%
|
-27% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.